Latest Conference Articles

DCAT Week 2025: Impact of Geopolitical Climate on Biopharma

March 18th 2025

PharmTech sat down with Joseph Principe, chief commercial officer at Abzena ahead of DCAT Week 2025 to get his perspective on how the geopolitical climate is impacting the industry.

DCAT Week 2025: Quality and Compliance for Animal-derived Products

March 18th 2025

Pharmaceutical Technology® discusses the quality and compliance issues surrounding the use of animal-derived ingredients in the bio/pharma industry with Roger Viney, chief commercial officer of ICE Pharma.

DCAT Week 2025: A Discussion on Aseptic Processing for Sterile Injectable Manufacturing

March 18th 2025

Lidia Serina, PhD, head of Development Services at Simtra BioPharma Solutions, discusses the challenges with maintaining aseptic integrity in sterile injectable pharmaceutical manufacturing.

DCAT Week 2025: Recognizing the Value of CDMOs

March 18th 2025

Pharmaceutical Technology® chats with Simon Wright from Almac Pharma Services about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.

Shilpa Biologicals and mAbTree Biologics to Collaborate on Novel Immuno-Oncology Asset

March 18th 2025

The partnership aims to develop and commercialize a novel checkpoint inhibitor for immuno-oncology applications.

DCAT Member Companies Present Latest News to Start DCAT Week 2025

March 17th 2025

DCAT

The Member Company Announcement Forum is the kickoff event of the annual DCAT Week in New York City, which is being held from March 17–20.

DCAT Week 2025: Packaging Innovations

March 17th 2025

Pharmaceutical Technology® spoke with Peter Belden, president of Tjoapack US, ahead of DCAT Week 2025 to discuss recent innovations in bio/pharmaceutical packaging.

Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025

March 17th 2025

DCAT

This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.

DCAT Week 2025: Challenges of Expanding Market Demand

March 17th 2025

As part of our coverage of this year’s DCAT Week, Pharmaceutical Technology® spoke with Hamilton Lenox, chief commercial officer at LGM Pharma about the expanding pharma market and the challenges such demand creates.

DCAT Week 2025: Helping Innovators Progress

March 17th 2025

In an interview with Pharmaceutical Technology®, Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.